Bausch + Lomb Reports Second Quarter Revenue Growth, Raises Full-Year Guidance
Published on July 31, 2025
VAUGHAN, Ontario—Global eye health company Bausch + Lomb Corporation (NYSE/TSX: BLCO) announced yesterday second-quarter 2025 financial results, demonstrating total reported revenue of $1.278 billion for the second quarter of 2025, an increase of $62 million, or 5 percent, compared with the same period last year. Excluding the favorable impact of foreign exchange of $21 million, revenue increased by approximately 3 percent on a constant currency basis. The vision care segment had a strong quarter led by contact lenses and the company’s dry eye portfolio, with reported revenue increasing 8 percent to $753 million. Further, the company raised its 2025 financial outlook, now expecting full-year revenue to be in a range of $5.050 billion to $5.150 billion, up from its previous guidance in April of $5.000 billion to $5.100 billion.